邁信林(688685.SH):上半年淨利潤1775.75萬元,同比下降14.17%
格隆匯8月24日丨邁信林(688685.SH)公佈2023年半年度報吿,報吿期實現營業收入1.47億元,同比增長10.73%;歸屬於上市公司股東的淨利潤1775.75萬元,同比下降14.17%;歸屬於上市公司股東的扣除非經常性損益的淨利潤1537.59萬元,同比下降8.68%;基本每股收益0.16元。
收入比上年同期增加的主要原因系公司募投項目部分完成投建,同時對工藝技術與設備進行了升級,整體產能得到有效提高,並且在完成鄭飛機械收購後,擴大了相應市場份額,銷售收入有所增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.